Search

Your search keyword '"Choi, Hyun Jin"' showing total 878 results

Search Constraints

Start Over You searched for: Author "Choi, Hyun Jin" Remove constraint Author: "Choi, Hyun Jin"
878 results on '"Choi, Hyun Jin"'

Search Results

2. Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

5. Baseline characteristics of participants enrolled in the KoreaN cohort study for Outcomes in patients With Pediatric Chronic Kidney Disease (KNOW-Ped CKD)

14. Incidence of and risk factors for short stature in children with chronic kidney disease: results from the KNOW-Ped CKD

18. Efficacy and safety of losartan in childhood immunoglobulin A nephropathy: a prospective multicenter study

25. Dyslipidemia in pediatric CKD patients: results from KNOW-PedCKD (KoreaN cohort study for Outcomes in patients With Pediatric CKD)

27. Mental health and psychosocial adjustment in pediatric chronic kidney disease derived from the KNOW-Ped CKD study

36. Figure S1 from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

37. Supplementary Figure 3 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

38. Supplemental Table 1 from Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer

39. Supplemental Table 2 from Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer

40. Supplementary Figure 4 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

41. Supplementary Figure 1 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

42. Supplementary Figure 6 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

43. Supplementary information from Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

44. Supplemental Methods from Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer

45. Supplementary Figure 5 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

46. Supplementary Figure 2 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

47. Supplementary Figure Legends from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

48. Data from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

Catalog

Books, media, physical & digital resources